Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Cobal G 300 mg/500 mcg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Cobal G 300 mg/500 mcg Tablet is a combination of two medicines: Gabapentin and Methylcobalamin. Gabapentin is an alpha 2 delta ligand which decreases pain by modulating calcium channel activity of the nerve cells. Methylcobalamin is a form of vitamin B which helps in the production of myelin, a substance that protects nerve fibers and rejuvenates damaged nerve cells. Together, they relieve neuropathic pain (pain from damaged nerves).
Cobal G 300 mg/500 mcg Tablet may cause excessive drowsiness and calmness with alcohol.
WEIGH RISKS VS BENEFITS
Cobal G 300 mg/500 mcg Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Cobal G 300 mg/500 mcg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby. Baby should be monitored for excessive sleepiness and weight gain.
Cobal G 300 mg/500 mcg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Cobal G 300 mg/500 mcg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Cobal G 300 mg/500 mcg Tablet may be needed. Please consult your doctor.
There is limited information available on the use of Cobal G 300 mg/500 mcg Tablet in patients with liver disease. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Cobal G 300 mg/500 mcg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.